Imugex

Shipping cost plus VAT not included , delivery in 7-14 business days

Categories: Diagnostics / Diagnostics

Product name			BCR/ABL gene fusion detection probe, BCR/ABL (CE-IVD)
Catalog No			FP-003
Supplier’s Catalog No			FP-003
Supplier			Wuhan Healthcare Biotech
Source antigen			BCR/ABL
Reactivity			BCR/ABL
Cross reactivity			None
Applications			Fluorescence In Situ Hybridization (FISH)
Molecular weight			N/A

Storage			-20°C
Other names
Grade			Molecular diagnostic grade
Purity			N/A
Form			Liquid
Reactivity life			12 months when stored properly according to instructions
Note			For Professional In Vitro diagnostics
Description			BCR/ABL fusion gene is a common cytogenetic anomaly in patients with chronic myelocytic leukemia (CML). The BCR/ABL fusion gene can be found in 90% of the CML patients. The prognosis of patients with BCR/ABL fusion gene is poor. It is clinically possible to use the BCR/ABL fusion gene to selectively use the molecular targeted therapeutic drugs . In addition, clinicians can combine other signs of patients to identify patients more effectively. The ABL probe was labeled with orange red dye and the green dye was used to mark the BCR probe. In situ hybridization technique could be used to combine the two probes into the target detection site.